Affluent Medical Valuation
| AFME Stock | 1.60 0.06 3.61% |
Based on Macroaxis valuation methodology, the firm appears to be overvalued. Affluent Medical SAS shows a prevailing Real Value of USD1.42 per share. The current price of the firm is USD1.6. Our model approximates the value of Affluent Medical SAS from analyzing the firm fundamentals such as return on equity of -0.36, and Operating Margin of (8.42) % as well as examining its technical indicators and probability of bankruptcy.
Overvalued
Today
Please note that Affluent Medical's price fluctuation is very risky at this time. Calculation of the real value of Affluent Medical SAS is based on 3 months time horizon. Increasing Affluent Medical's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
Since Affluent Medical is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Affluent Stock. However, Affluent Medical's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 1.6 | Real 1.42 | Hype 1.6 | Naive 1.51 |
The real value of Affluent Stock, also known as its intrinsic value, is the underlying worth of Affluent Medical SAS Company, which is reflected in its stock price. It is based on Affluent Medical's financial performance, growth prospects, management team, or industry conditions. The intrinsic value of Affluent Medical's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, or news.
Estimating the potential upside or downside of Affluent Medical SAS helps investors to forecast how Affluent stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Affluent Medical more accurately as focusing exclusively on Affluent Medical's fundamentals will not take into account other important factors: Affluent Medical Total Value Analysis
Affluent Medical SAS is presently forecasted to have takeover price of 50.42 M with market capitalization of 30.06 M, debt of 17 M, and cash on hands of 11.41 M. Please note that takeover price may be misleading and is a subject to mistakes in financial statements. We encourage investors to thoroughly investigate all of the Affluent Medical fundamentals before making investing decisions based on enterprise value of the company| Takeover Price | Market Cap | Debt Obligations | Cash |
50.42 M | 30.06 M | 17 M | 11.41 M |
Affluent Medical Asset Utilization
One of the ways to look at asset utilization of Affluent is to check how much profit was generated for every dollar of assets it reports. Affluent Medical SAS shows a negative utilization of assets of -0.12 percent, losing USD0.001162 for each dollar of assets held by the firm. Unsuccessful asset utilization signifies that the company is being less effective with each dollar of assets it shows. Put another way, asset utilization of Affluent Medical SAS shows how unproductive it operates for each dollar spent on its assets.Affluent Medical Ownership Allocation
Affluent Medical holds a total of 20.6 Million outstanding shares. Over half of Affluent Medical's outstanding shares are owned by other corporate entities. These other corporate entities are typically referred to as corporate investors that acquire positions in a given instrument to benefit from reduced trade commissions. Consequently, these institutions are subject to different rules and regulations than regular investors in Affluent Medical. Please watch out for any change in the institutional holdings of Affluent Medical SAS as this could mean something significant has changed or is about to change at the company. Please note that no matter how many assets the company secures, if the real value of the firm is less than the current market value, you may not be able to make money on it.Affluent Medical Profitability Analysis
Net Loss for the year was (14.82 M) with loss before overhead, payroll, taxes, and interest of (1.29 M).Please note that valuation analysis is one of the essential comprehensive assessments in business. It evaluates Affluent Medical's worth, which you can determine by considering its current assets, liabilities and future cash flows. The investors' valuation analysis is an important metric that will give you a perspective on different companies. It helps you know the worth of the potential investment in Affluent Medical and how it compares across the competition.
About Affluent Medical Valuation
The stock valuation mechanism determines Affluent Medical's current worth on a weekly basis. Our valuation model uses a comparative analysis of Affluent Medical. We calculate exposure to Affluent Medical's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of Affluent Medical's related companies.8 Steps to conduct Affluent Medical's Valuation Analysis
Company's valuation is the process of determining the worth of any company in monetary terms. It estimates Affluent Medical's potential worth based on factors such as financial performance, market conditions, growth prospects, and overall economic environment. The result of company valuation is a single number representing a Company's current market value. This value can be used as a benchmark for various financial transactions such as mergers and acquisitions, initial public offerings (IPOs), or private equity investments. To conduct Affluent Medical's valuation analysis, follow these 8 steps:- Gather financial information: Obtain Affluent Medical's financial statements, including balance sheets, income statements, and cash flow statements.
- Determine Affluent Medical's revenue streams: Identify Affluent Medical's primary sources of revenue, including products or services offered, target markets, and pricing strategies.
- Analyze market data: Research Affluent Medical's industry and market trends, including the size of the market, growth rate, and competition.
- Establish Affluent Medical's growth potential: Evaluate Affluent Medical's management, business model, and growth potential.
- Determine Affluent Medical's financial performance: Analyze its financial statements to assess its historical performance and future potential.
- Choose a valuation method: Consider the Company's specific circumstances and choose an appropriate valuation method, such as the discounted cash flow (DCF) or comparable analysis method.
- Calculate the value: Apply the chosen valuation method to the financial information and market data to calculate Affluent Medical's estimated value.
- Review and adjust: Review the results and make necessary adjustments, considering any relevant factors that may have been missed or overlooked.
Complementary Tools for Affluent Stock analysis
When running Affluent Medical's price analysis, check to measure Affluent Medical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Affluent Medical is operating at the current time. Most of Affluent Medical's value examination focuses on studying past and present price action to predict the probability of Affluent Medical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Affluent Medical's price. Additionally, you may evaluate how the addition of Affluent Medical to your portfolios can decrease your overall portfolio volatility.
| Technical Analysis Check basic technical indicators and analysis based on most latest market data | |
| Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
| Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings | |
| FinTech Suite Use AI to screen and filter profitable investment opportunities | |
| Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios |